FindTrial
Sign In

Endoscopic Radiofrequency Ablation VS Photodynamic Therapy for inoperable perihilar or peripheral cholangiocarcinoma

Control study between endoscopic radiofrequency ablation and photodynamic therapy for inoperable perihilar or peripheral cholangiocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004960
Enrollment
Unknown
Registered
2014-01-15
Start date
2014-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholangiocarcinoma

Interventions

control group:Photodynamic therapy
Study Group:Endoscopic Radiofrequency Ablation

Sponsors

Hangzhou First people's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
41 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inoperable perihilar or peripheral cholangiocarcinoma: Bismuth-Corlette IV lesions, advanced type III lesions containing T3 tumors, or other types II-III tumors with lymphatic or liver metastasis; and age older than 80 years or other serious complications.

Exclusion criteria

Exclusion criteria: Intrahepatic cholangiocarcinoma, and cholangiocarcinoma which can receive surgery (including Bismuth Corlette - I, II and III cholangiocarcinoma T1-2 and without obvious lymph node and liver metastasis), patients who cannot tolerate ERCP with severe complications.

Design outcomes

Primary

MeasureTime frame
Karnofsky scor;—

Secondary

MeasureTime frame
WHITE BLOOD CELL;Blood neutrophils ratio;serum liver function index;serum Tumor markers;Tumor stages;ERCP Operating time;PDT dose;RFA power;Complication rate;Survival time;bile duct unobstructed tim;—

Countries

China

Contacts

Public ContactLi Zhaoshen
frank_kent@sina.com+86 13588807313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026